SCHEMBL8636307

SCHEMBL8636307

O=C(O)C(c1ccc(CCCO)cc1)C1CCCC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 2/20 0.49
ALOX5 P09917 2/20 0.43
HDAC6 Q9UBN7 1/20 0.43
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HTR1E P28566 1/20 0.41
KMT2A Q03164 1/20 0.41
S1PR3 Q99500 1/20 0.41
AGTR2 P50052 1/20 0.40
EPHX2 P34913 3/20 0.40
EPHX1 P07099 1/20 0.40
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8634916 0.91 CHRM3 (0.47) CHRM3ALOX5HDAC6MEN1LMNA
SCHEMBL27483589 0.84 CHRM3 (0.46) CHRM3ALOX5HDAC6MEN1LMNA
SCHEMBL27388408 0.84 CHRM3 (0.46) CHRM3ALOX5HDAC6MEN1LMNA
SCHEMBL27361339 0.80 BDKRB2 (0.48) CHRM3ALOX5HDAC6MEN1LMNA
SCHEMBL1069660 0.80 ALOX5 (0.45) CHRM3ALOX5HDAC6MEN1LMNA
SCHEMBL7013582 0.80 ALOX5 (0.45) CHRM3ALOX5HDAC6MEN1LMNA
SCHEMBL27368748 0.80 BDKRB2 (0.48) CHRM3ALOX5HDAC6MEN1LMNA
SCHEMBL10006210 0.80 NPC1 (0.46) CHRM3ALOX5HDAC6MEN1LMNA
SCHEMBL4242909 0.76 ALOX5 (0.49) CHRM3ALOX5HDAC6MEN1LMNA
SCHEMBL28622389 0.76 HTR1E (0.65) CHRM3ALOX5HDAC6MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5776964-A HYPOTENSIVE AGENTS; ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1998-07-07 US disclosed
US-5521206-A HYPOTENSIVE AGENTS, TREATMENT OF ATHEROSCLEROSIS BAYER AKTIENGESELLSCHAFT (DE) 1996-05-28 US disclosed